Steven Mah

Stock Analyst at TD Cowen

(1.99)
# 2,967
Out of 4,876 analysts
30
Total ratings
31.03%
Success rate
7.87%
Average return

Stocks Rated by Steven Mah

Twist Bioscience
Nov 26, 2024
Reiterates: Buy
Price Target: $58
Current: $35.93
Upside: +61.42%
BioLife Solutions
Nov 13, 2024
Maintains: Buy
Price Target: $28$31
Current: $21.50
Upside: +44.19%
Ginkgo Bioworks Holdings
Mar 1, 2024
Maintains: Outperform
Price Target: $280$120
Current: $9.46
Upside: +1,168.50%
Recursion Pharmaceuticals
Jan 26, 2024
Initiates: Market Perform
Price Target: n/a
Current: $5.03
Upside: -
Schrödinger
Jan 26, 2024
Initiates: Outperform
Price Target: $42
Current: $20.61
Upside: +103.78%
AbCellera Biologics
Feb 28, 2023
Initiates: Outperform
Price Target: n/a
Current: $3.61
Upside: -
OmniAb
Feb 22, 2023
Initiates: Outperform
Price Target: $10
Current: $1.70
Upside: +488.24%
Absci
Aug 12, 2022
Upgrades: Outperform
Price Target: n/a
Current: $2.62
Upside: -
Codexis
Jul 15, 2022
Maintains: Outperform
Price Target: $39$21
Current: $2.39
Upside: +778.66%
Natera
Jul 6, 2021
Maintains: Overweight
Price Target: $150$155
Current: $167.96
Upside: -7.72%
Initiates: Overweight
Price Target: $28
Current: $1.24
Upside: +2,158.06%
Maintains: Overweight
Price Target: $135$140
Current: $19.68
Upside: +611.38%
Upgrades: Overweight
Price Target: $20$52
Current: $1.29
Upside: +3,931.01%
Upgrades: Overweight
Price Target: $340$415
Current: $94.79
Upside: +337.81%
Maintains: Overweight
Price Target: $168$250
Current: $28.87
Upside: +765.95%